Medicef Pharma
Medicef Pharma is an Indian pharmaceutical contract manufacturer founded in 2010, specializing in Amoxicillin and Amoxicillin + Clavulanic Acid formulations (tablets, capsules, suspensions, sachets). It serves 25+ enterprise pharma clients including Abbott, Lupin, and Cadila, exporting to 40+ countries under EU-GMP and WHO-GMP certifications.
- Company typePrivate
- Founded2010
- HeadquartersDelhi, India
- Headcount501–1,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Medicef Pharma does
Medicef Pharma is an Indian privately held pharmaceutical contract manufacturer founded in 2010 by Vijay Kumar Aggarwal, specializing exclusively in beta-lactam antibiotics — primarily Amoxicillin and Amoxicillin + Clavulanic Acid (Co-Amoxiclav) combinations. Operations are anchored by a single state-of-the-art manufacturing facility in Baddi, Himachal Pradesh, recognized as Asia's largest pharmaceutical hub, with corporate headquarters in Rohini, New Delhi. The company's product range spans tablets (film-coated, dispersible, chewable), capsules, powder for oral suspension, and single-dose sachets, offered across multiple dosage strengths for pediatric and adult populations.
The manufacturing platform is purpose-built for moisture-sensitive beta-lactam processing, featuring low relative humidity environments controlled by dedicated AHUs and dehumidifiers, automated compression machines with automatic weight control and metal detection, automated film-coating systems, in-house HPLC quality analysis, ICH-compliant stability testing, and purified water systems. Single-shift monthly capacity stands at 50 million tablets, 5 million capsules, 3 million powder-for-oral-suspension units, and 8 million sachets, employing over 700 trained staff. Formulation and development capabilities include pre-formulation studies, stability and degradation studies, and technical dossier preparation for regulatory submissions.
Medicef generates revenue through a pure B2B contract manufacturing and finished/semi-finished formulation supply model, selling exclusively to other pharmaceutical companies rather than through retail channels. The customer base spans most of India's top pharma names — Abbott, Ajanta Pharma, Alkem, Cadila Healthcare, Emcure, Glenmark, Intas, IPCA, Lupin, Macleods, Torrent, Wockhardt, Zydus Cadila — alongside export distribution to regulated and semi-regulated markets in the EU, GCC, MENA, Russia/CIS, Latin America, and Africa. The company has crossed $40M+ USD in global annual sales and holds GMP certifications from 40+ country regulatory authorities, including EU-GMP (Hungary), WHO-GMP, ISO 9001:2015, ISO 14001, and ISO 45001.
Medicef Pharma firmographics
Firmographics- Name
- Medicef Pharma
- Legal name
- Medicef Pharma
- Website
- https://medicefpharma.com
- Company type
- Private
- Founded year
- 2010
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Medicef Pharma is an Indian pharmaceutical contract manufacturer founded in 2010, specializing in Amoxicillin and Amoxicillin + Clavulanic Acid formulations (tablets, capsules, suspensions, sachets). It serves 25+ enterprise pharma clients including Abbott, Lupin, and Cadila, exporting to 40+ countries under EU-GMP and WHO-GMP certifications.
- Ownership category
- akta.pro rank
Where Medicef Pharma is headquartered
LocationHeadquarters
- HQ city
- Delhi
- HQ country
- India
- HQ region
- Asia
Offices2 records
Markets served
Medicef Pharma business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales
Revenue model
- Contract Manufacturing Services: Medicef Pharma operates as a contract manufacturer producing pharmaceutical formulations for other pharmaceutical companies. They offer production in a range of dosage forms and packaging options including uncoated, film coated, chewable and dispersible tablets, capsules, oral powder for suspension, and sachets.
- Finished & Semi-Finished Formulations: Manufacturing and sale of Amoxicillin and Amoxicillin & Clavulanic Acid finished and semi-finished formulations to pharmaceutical companies globally
Go-to-market motion1 record
Distribution channels1 record
Marketing channels8 records
Medicef Pharma product offering
Product offeringCore offering
Medicef Pharma is a B2B contract manufacturer of finished pharmaceutical formulations, specializing in antibiotic products based on Amoxicillin and Amoxicillin + Clavulanic Acid (Co-Amoxiclav). It produces tablets, capsules, powder for oral suspension, and sachets from a WHO-cGMP and EU-GMP certified facility in Baddi, Himachal Pradesh, supplying leading generic and research-based pharmaceutical companies in India and international markets.
Product overview
Medicef Pharma is a pharmaceutical formulation manufacturer specializing in Amoxicillin and Amoxicillin + Clavulanic Acid (Co-Amoxiclav) antibiotic products. The company's product portfolio comprises four main product categories: Tablets (including Film Coated, Dispersible, and Chewable formulations), Powder for Oral Suspension (drops and DS formulations), Capsules, and Sachets. These products are offered in various dosage strengths to serve diverse patient populations from pediatric to adult. Medicef Pharma positions itself as "The Clav People" in the global market, focusing on beta-lactam antibiotics with a complete vertical range from semi-finished to finished formulations.
Differentiator
Problem solved
Functional benefit
Products and services
- Amoxicillin Tablets
Quantifiable outcome
- 40+ Million USD in global sales per annum
- +2 more outcomes
Companies that use Medicef Pharma
Customer profileNamed customers27 records
Segments3 records
Ideal customer profiles2 records
Medicef Pharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
Medicef Pharma partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Purobien Nutrition UKminorOne of the group companies of Medicef Pharma. Aims to be a global leader in sports nutrition and health supplements, providing quality health supplements including whey protein supplements.
Scale indicators8 records
Recent moves6 records
Expansion highlights5 records
Medicef Pharma competitors and assessment
Company assessmentRegional players
- Unichem Laboratories: Indian pharma manufacturer with focus on anti-infectives and chronic therapies, with international presence. Comparable in manufacturing scale and therapeutic overlap, though with greater branded finished-dosage emphasis than pure CM.
Direct peers
- Macleods Pharmaceuticals: Privately-held Indian pharma manufacturer with broad anti-infectives portfolio and significant contract manufacturing operations. Direct comparability in scale, ownership structure, therapeutic focus, and B2B go-to-market.
- Mankind Pharma: Major Indian pharma company with leadership in antibiotics and acute therapy segment. Comparable in domestic market positioning in anti-infectives and similar contract manufacturing reliance on partners for some product lines.
- Alkem Laboratories: Indian pharmaceutical manufacturer with strong beta-lactam and antibiotic franchise and significant domestic formulation presence. Most directly comparable Indian peer given overlapping therapeutic focus in anti-infectives and similar B2B channels.
- Hetero Labs: Large Indian pharmaceutical manufacturer and contract manufacturer with strong antibiotics and ARV franchise. Comparable as a vertically integrated Indian API-plus-formulation manufacturer serving regulated and semi-regulated export markets.
Broad incumbents
- Lupin: Major Indian pharma manufacturer with strong anti-infectives and global formulation footprint. Comparable in contract manufacturing exposure to Indian majors and overseas markets, though far larger and more diversified.
- Cipla: One of India's largest pharma companies with dominant anti-infectives franchise and global reach. Comparable as an Indian anti-infectives manufacturer serving both domestic and international regulated markets.
- Ipca Laboratories: Established Indian pharma manufacturer with anti-infectives and contract manufacturing. Comparable in manufacturing scale, API-to-formulation integration, and export orientation, though broader portfolio than Medicef's beta-lactam focus.
- Zydus Cadila (Cadila Healthcare): Top Indian pharma company with broad anti-infectives portfolio and significant global operations. Comparable in beta-lactam manufacturing heritage and B2B contract manufacturing relationships, though much larger and more diversified.
- Aurobindo Pharma: Major Indian pharma manufacturer with leading antibiotics franchise and large export business. Comparable in scale of contract manufacturing and global regulatory certifications, though broader portfolio across multiple therapeutic areas.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Medicef Pharma social profiles
Digital presenceMedicef Pharma compliance and trust
Trust signalCompliance27 records
Medicef Pharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
Medicef Pharma leadership team
Management profileNumber of profiles
Profiles1 record
Medicef Pharma subsidiaries and ownership
Company hierarchySubsidiaries4 records
Medicef Pharma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Medicef Pharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Medicef Pharma
What does Medicef Pharma do?
Medicef Pharma is a B2B contract manufacturer of finished pharmaceutical formulations, specializing in antibiotic products based on Amoxicillin and Amoxicillin + Clavulanic Acid (Co-Amoxiclav). It produces tablets, capsules, powder for oral suspension, and sachets from a WHO-cGMP and EU-GMP certified facility in Baddi, Himachal Pradesh, supplying leading generic and research-based pharmaceutical companies in India and international markets.
Is Medicef Pharma a public or private company?
Medicef Pharma is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Medicef Pharma founded?
Medicef Pharma was founded in 2010. It employs 501 to 1,000 people.
Where is Medicef Pharma based?
Medicef Pharma is headquartered in Delhi, India, in the Asia region.
How does Medicef Pharma make money?
Two revenue lines are on record. Contract Manufacturing Services are the primary driver. The others are finished & Semi-Finished Formulations.
Who are Medicef Pharma's main competitors?
Unichem Laboratories is listed as a regional player. Direct peers are Macleods Pharmaceuticals, Mankind Pharma, Alkem Laboratories and Hetero Labs. Broad incumbents are Lupin, Cipla, Ipca Laboratories, Zydus Cadila (Cadila Healthcare) and Aurobindo Pharma.
Does Medicef Pharma have an API?
No public API is recorded for Medicef Pharma.